van Zuuren, E. J., Fedorowicz, Z., & Schoones, J. (2016). Interventions for female pattern hair loss. Cochrane Database of Systematic Reviews, 2016(5), CD007628. https://doi.org/10.1002/14651858.CD007628.pub4
Suchonwanit, P., Thammarucha, S., & Leerunyakul, K. (2019). Minoxidil and its use in hair disorders: a review. Drug Design Development and Therapy, 13, 2777–2786. https://doi.org/10.2147/DDDT.S214907
Nestor, M. S., Ablon, G., Gade, A., Han, H., & Fischer, D. L. (2021). Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. Journal of Cosmetic Dermatology, 20(12), 3759–3781. https://doi.org/10.1111/jocd.14537
Gupta, A. K., Talukder, M., & Williams, G. (2022). Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. Journal of Dermatological Treatment, 33(7), 2946–2962. https://doi.org/10.1080/09546634.2022.2109567
Garcia-Argibay, M., Hiyoshi, A., Fall, K., & Montgomery, S. (2022). Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide. JAMA Network Open, 5(12), e2248135. https://doi.org/10.1001/jamanetworkopen.2022.48135
Penha, M. A., Miot, H. A., Kasprzak, M., & Müller Ramos, P. (2024). Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatology, 160(6), 600–605. https://doi.org/10.1001/jamadermatol.2024.0284
Asilian, A., Farmani, A., & Saber, M. (2024). Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial. Journal of Cosmetic Dermatology, 23(3), 949–957. https://doi.org/10.1111/jocd.16086
Ong, M. M., Li, Y., & Lipner, S. R. (2026). Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations. American Journal of Clinical Dermatology, 27(1), 101–119. https://doi.org/10.1007/s40257-025-00990-4